October 31, 2008

BRISTOL MYERS: 3rd Party Objection to YES Permits Still Pending

COMPANIES:
Subscribe

The third party objection to Yes Pharmaceutical Development Services GmbH’s marketing authorizations over clopidogrel besylate products before the German Federal Institute for Drugs and Medical Devices (Bfarm) is still pending,…

TO CONTINUE READING,LOGIN or
TOPICS: Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: